Localized bullous pemphigoid arising within sites of radiation in the context of immune checkpoint inhibitor therapy
Clinical and Experimental Dermatology · 17.08.2026 · 51 (9) · 1716-1718
DOI: 10.1093/ced/llag156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 17.08.2026. Verfasst von W Austin Wyant und 5 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
There is minimal literature on the development of localized bullous pemphigoid exclusively in previously irradiated skin. We report two patients with bullous pemphigoid strikingly localized to areas of previous radiation therapy that occurred in the setting of concomitant immune checkpoint inhibitor therapy.
Autor:innen und Institutionen
- Harvard Medical School, Boston, MA, USA.
- Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
ORCID-Profile: W Austin Wyant
Zitieren
APA
Wyant, W. A., Drake, L., Ji-Xu, A., Singhal, D., Desai, A. M., & Iriarte, C. (2026). Localized bullous pemphigoid arising within sites of radiation in the context of immune checkpoint inhibitor therapy. Clinical and Experimental Dermatology, 51(9), 1716-1718. https://doi.org/10.1093/ced/llag156
Vancouver
Wyant WA, Drake L, Ji-Xu A, Singhal D, Desai AM, Iriarte C. Localized bullous pemphigoid arising within sites of radiation in the context of immune checkpoint inhibitor therapy. Clinical and Experimental Dermatology. 2026;51(9):1716-1718. doi:10.1093/ced/llag156
BibTeX
@article{Wyant2026,
author = {Wyant, W Austin and Drake, Lara and Ji-Xu, Antonio and Singhal, Dhruv and Desai, Anupam M and Iriarte, Christopher},
title = {Localized bullous pemphigoid arising within sites of radiation in the context of immune checkpoint inhibitor therapy},
journal = {Clinical and Experimental Dermatology},
year = {2026},
volume = {51},
number = {9},
pages = {1716--1718},
doi = {10.1093/ced/llag156}
}
EUVIMED